https://www.selleckchem.com/pr....oducts/solcitinib.ht
CONCLUSIONS Our arthroplasty care practitioner service allowed us to identify increased pain and stop using the ASR XL over 3 years before the implant was recalled. The revised patients had similar functional outcome to those unrevised. Poorly performing implants need to be identified earlier.Background Recent American College of Cardiology/American Heart Association (ACC/AHA) Primary Prevention Guidelines recommended considering low-dose aspirin therapy only among adults 40-70 years of age who are at higher atherosclerotic cardiovas
Like
Comment
Share
